功能基因组学鉴定16p11.2精神分裂症相关位点的调控风险变异rs4420550
该研究综合运用生物信息学与分子生物学方法,包括表达数量性状位点分析、表观基因组特征鉴定、荧光素酶报告实验、染色质构象捕获、CRISPR/Cas9同源定向基因组编辑、RNA测序和ATAC-Seq,对16p11.2精神分裂症GWAS风险位点进行功能刻画。研究发现rs4420550位于DNA增强子区域,与MAPK3和TAOK2启动子存在物理相互作用,并影响16p11.2区域基因转录和染色质可及性。
要点
- rs4420550位于DNA增强子区,与MAPK3和TAOK2启动子物理互作。
- CRISPR/Cas9编辑证实rs4420550调控16p11.2基因转录和染色质可及性。
- rs4420550-[A/A]细胞增殖率显著高于rs4420550-[G/G]细胞。
核心结论
- rs4420550是16p11.2位点的功能性风险变异,可调控MAPK3等基因转录。
研究设计与样本
- 采用表达数量性状位点分析、表观基因组特征鉴定、荧光素酶报告实验、染色质构象捕获、CRISPR/Cas9同源定向基因组编辑、RNA测序和ATAC-Seq等多种方法。
主要发现
- 16p11.2精神分裂症GWAS风险变异与脑内多个基因mRNA水平显著相关,MAPK3距风险变异约200 kb。
- rs4420550在精神分裂症GWAS中p=2.36×10-9,位于DNA增强子区并经荧光素酶实验验证。
- rs4420550区域与MAPK3启动子和TAOK2启动子物理互作。
- rs4420550-[A/A]细胞增殖率显著高于rs4420550-[G/G]细胞。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Genome-wide association studies (GWASs) have reported hundreds of genomic loci associated with schizophrenia, yet identifying the functional risk variations is a key step in elucidating the underlying mechanisms. METHODS: We applied multiple bioinformatics and molecular approaches, including expression quantitative trait loci analyses, epigenome signature identification, luciferase reporter assay, chromatin conformation capture, homology-directed genome editing by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/Cas9), RNA sequencing, and ATAC-Seq (assay for transposase-accessible chromatin using sequencing). RESULTS: We found that the schizophrenia GWAS risk variations at 16p11.2 were significantly associated with messenger RNA levels of multiple genes in human brain, and one of the leading expression quantitative trait loci genes, MAPK3, is located ∼200 kb away from these risk variations in the genome. Further analyses based on the epigenome marks in human brain and cell lines suggested that a noncoding single nucleotide polymorphism, rs4420550 (p = 2.36 × 10-9 in schizophrenia GWAS), was within a DNA enhancer region, which was validated via in vitro luciferase reporter assays. The chromatin conformation capture experiment showed that the rs4420550 region physically interacted with the MAPK3 promoter and TAOK2 promoter. Precise CRISPR/Cas9 editing of a single base pair in cells followed by RNA sequencing further confirmed the regulatory effects of rs4420550 on the transcription of 16p11.2 genes, and ATAC-Seq demonstrated that rs4420550 affected chromatin accessibility at the 16p11.2 region. The rs4420550-[A/A] cells showed significantly higher proliferation rates compared with rs4420550-[G/G] cells. CONCLUSIONS: These results together suggest that rs4420550 is a functional risk variation, and this study illustrates an example of comprehensive functional characterization of schizophrenia GWAS risk loci.
引用
- Chang H, Cai X, Li HJ, et al. Functional Genomics Identify a Regulatory Risk Variation rs4420550 in the 16p11.2 Schizophrenia-Associated Locus. Biol Psychiatry. 2020. PMID: 33246552. doi:10.1016/j.biopsych.2020.09.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。